Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dialysis Drug Reimbursement Should Be Based Solely On ASP, MedPAC Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Medicare Payment Advisory Committee unanimously recommends average sales price-based reimbursement for dialysis drugs in all settings. More timely updating of payment rates is cited as the main advantage of ASP-based reimbursement over reimbursement based on average acquisition payment.
Advertisement

Related Content

MedPAC Recommends Outpatient Rx Handling Fee For Hospital Pharmacies
MedPAC Recommends Outpatient Rx Handling Fee For Hospital Pharmacies

Topics

Advertisement
UsernamePublicRestriction

Register

PS062042

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel